Works matching DE "DRUG therapy for Parkinson's disease"

Results: 806

A Structural Model of Health-Related Quality of Life in Parkinson’s Disease Patients.

Published in:

2015

By:

Lee, JuHee;
Choi, MoonKi;
Jung, Dukyoo;
Sohn, Young H.;
Hong, JinYong

Publication type:

Journal Article

Correction to: Amantadine extended release capsules (GOCOVRI<sup>®</sup>) in Parkinson's disease: a profile of its use in the USA.

Published in:

2023

By:

Al-Salama, Zaina T.

Publication type:

Correction Notice

Targeting toxic forms of α-synuclein with immunotherapy could alter the progression of Parkinson's disease.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 11, p. 467, doi. 10.1007/s40267-022-00950-6

By:

Paik, Julia

Publication type:

Article

Amantadine extended release capsules (GOCOVRI<sup>®</sup>) in Parkinson's disease: a profile of its use in the USA.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 203, doi. 10.1007/s40267-022-00912-y

By:

Al-Salama, Zaina T.

Publication type:

Article

The relationship between temperament and depression in Parkinson's disease patients under dopaminergic treatment.

Published in:

Psychogeriatrics, 2019, v. 19, n. 1, p. 73, doi. 10.1111/psyg.12366

By:

Dogan, Bilge;
Akyol, Ali;
Memis, Cagdas O.;
Sair, Ahmet;
Akyildiz, Utku;
Sevincok, Levent

Publication type:

Article

Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study.

Published in:

Psychogeriatrics, 2014, v. 14, n. 2, p. 93, doi. 10.1111/psyg.12045

By:

Ishikawa, Kei‐Ichi;
Motoi, Yumiko;
Mizuno, Yoshikuni;
Kubo, Shin‐Ichiro;
Hattori, Nobutaka

Publication type:

Article

Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.

Published in:

Psychogeriatrics, 2013, v. 13, n. 2, p. 103, doi. 10.1111/j.1479-8301.2012.00432.x

By:

Tagai, Kenji;
Nagata, Tomoyuki;
Shinagawa, Shunichiro;
Tsuno, Norifumi;
Ozone, Motohiro;
Nakayama, Kazuhiko

Publication type:

Article

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.

Published in:

Psychogeriatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1111/j.1479-8301.2012.00403.x

By:

Kulkantrakorn, Kongkiat;
Tanyakitpisal, Panas;
Towanabut, Somchai;
Dejthevaporn, Charungthai;
Rangseekajee, Poonsri;
Pongpakdee, Sunsanee;
Laptikultham, Somsak;
Rodprasert, Kritsada;
Setthawatcharawanich, Suwanna;
Thinkhamrop, Bandit

Publication type:

Article

Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 289, doi. 10.1007/s00228-022-03438-4

By:

Oonk, N. G. M.;
Dorresteijn, L. D. A.;
van den Berg, A. D.;
van der Palen, J.;
Movig, K. L. L.;
Nijmeijer, H. W.;
van Kesteren, M. E.;
Koffijberg, H.

Publication type:

Article

Case report: cold medicines cause neuroleptic malignant-like syndrome in a patient with Parkinson's disease.

Published in:

2022

By:

JiYi, Xu;
Hantao, Song;
Lijiao, Zhao;
Bin, Qin

Publication type:

Case Study

Safety and efficacy of tolcapone in Parkinson's disease: systematic review.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 6, p. 817, doi. 10.1007/s00228-020-03081-x

By:

Artusi, Carlo Alberto;
Sarro, Lidia;
Imbalzano, Gabriele;
Fabbri, Margherita;
Lopiano, Leonardo

Publication type:

Article

Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 12, p. 1731, doi. 10.1007/s00228-020-02961-6

By:

Binde, Caroline D.;
Tvete, Ingunn F.;
Gåsemyr, Jørund I.;
Natvig, Bent;
Klemp, Marianne

Publication type:

Article

Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1299, doi. 10.1007/s00228-018-2497-2

By:

Senek, Marina;
Nyholm, Dag;
Nielsen, Elisabet I.

Publication type:

Article

Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 563, doi. 10.1007/s00228-017-2196-4

By:

Senek, Marina;
Aquilonius, Sten-Magnus;
Askmark, Håkan;
Bergquist, Filip;
Constantinescu, Radu;
Ericsson, Anders;
Lycke, Sara;
Medvedev, Alexander;
Memedi, Mevludin;
Ohlsson, Fredrik;
Spira, Jack;
Westin, Jerker;
Nyholm, Dag

Publication type:

Article

A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 4, p. 423, doi. 10.1007/s00228-016-2034-0

By:

Simon, N.;
Viallet, F.;
Boulamery, A.;
Eusebio, A.;
Gayraud, D.;
Azulay, J-P.

Publication type:

Article

Anticholinergic burden in Parkinson's disease inpatients.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 10, p. 1271, doi. 10.1007/s00228-015-1919-7

By:

Lertxundi, Unax;
Isla, Arantxazu;
Solinis, Maria Angeles;
Domingo-Echaburu, Saioa;
Hernandez, Rafael;
Peral-Aguirregoitia, Javier;
Medrano, Juan

Publication type:

Article

Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 8, p. 1011, doi. 10.1007/s00228-015-1881-4

By:

Crispo, James;
Fortin, Yannick;
Thibault, Dylan;
Emons, Matthew;
Bjerre, Lise;
Kohen, Dafna;
Perez-Lloret, Santiago;
Mattison, Donald;
Willis, Allison;
Krewski, Daniel

Publication type:

Article

Clozapine serum concentrations in dopamimetic psychosis in Parkinson's disease and related disorders.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 12, p. 1471, doi. 10.1007/s00228-014-1772-0

By:

Lutz, Ulrich;
Sirfy, Ahmad;
Wiatr, Gerlinde;
Altpaß, Danuta;
Farger, Gisbert;
Gasser, Thomas;
Karle, Kathrin;
Batra, Anil

Publication type:

Article

Preladenant, a selective adenosine A receptor antagonist, is not associated with QT/QTc prolongation.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 10, p. 1761, doi. 10.1007/s00228-013-1541-5

By:

Wang, Z.;
Xuan, F.;
Lin, W.;
Troyer, M.;
Tendolkar, A.;
Cutler, D.

Publication type:

Article

Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol- O-methyltransferase inhibitors in Parkinson's disease patients.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1493, doi. 10.1007/s00228-012-1281-y

By:

Ferrari, Marco;
Martignoni, Emilia;
Blandini, Fabio;
Riboldazzi, Giulio;
Bono, Giorgio;
Marino, Franca;
Cosentino, Marco

Publication type:

Article

Do Parkinson's disease patients disclose their adverse events spontaneously?

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 857, doi. 10.1007/s00228-011-1198-x

By:

Perez-Lloret, Santiago;
Rey, María;
Fabre, Nelly;
Ory, Fabienne;
Spampinato, Umberto;
Montastruc, Jean-Louis;
Rascol, Olivier

Publication type:

Article

Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 1, p. 83, doi. 10.1007/s00228-011-1084-6

By:

Arbouw, Maurits;
Movig, Kris;
Guchelaar, Henk-Jan;
Neef, Cees;
Egberts, Toine

Publication type:

Article

Characterizing dopaminergic neuron vulnerability using genome-wide analysis.

Published in:

Genetics, 2021, v. 218, n. 4, p. 1, doi. 10.1093/genetics/iyab081

By:

Davis, Jacinta;
Da Silva Santos, Claire;
Zavala, Narda Caudillo;
Gans, Nicholas;
Patracuolla, Daniel;
Fehrenbach, Monica;
Babcock, Daniel T.

Publication type:

Article

Management of psychiatric disorders in patients with parkinson's diseases.

Published in:

Indian Journal of Psychiatry, 2022, v. 64, p. 330, doi. 10.4103/indianjpsychiatry.indianjpsychiatry_29_22

By:

Tripathi, Adarsh;
Gupta, Pawan;
Bansal, Teena

Publication type:

Article

Parkinsonism-hyperpyrexia syndrome: A case report and review of literature.

Published in:: Indian Journal of Psychiatry, 2018, v. 60, n. 4, p. 499, doi. 10.4103/psychiatry.IndianJPsychiatry_113_18
Publication type:: Article

How to optimise medicines management for people with Parkinson’s disease in hospital.

Published in:

Nursing Older People, 2025, v. 37, n. 1, p. 16, doi. 10.7748/nop.2024.e1480

By:

Cox, Cindy Marguerite

Publication type:

Article

Apomorphine infusion could reduce periods of immobility in people with Parkinson's disease.

Published in:

Nursing Older People, 2019, v. 31, n. 2, p. 10, doi. 10.7748/nop.31.2.10.s8

By:

Sander, Ruth

Publication type:

Article

Research into treatments for neurodegenerative disorders.

Published in:: Nursing Older People, 2018, v. 30, n. 7, p. 11, doi. 10.7748/nop.30.7.11.s10
Publication type:: Article

'I was inspired by how patients and families cope': Parkinson's disease nurse specialist and older person's nurse fellow Carol Miller explains her passion for patient care.

Published in:: Nursing Older People, 2018, v. 30, n. 3, p. 16, doi. 10.7748/nop.30.3.16.s16
Publication type:: Article

Caring for patients with Parkinson's disease in general hospital settings.

Published in:

Nursing Older People, 2017, v. 29, n. 5, p. 30, doi. 10.7748/nop.2017.e861

By:

Queen, Vicky

Publication type:

Article

Management of levodopa for residents with Parkinson's disease.

Published in:

Nursing Older People, 2016, v. 28, n. 9, p. 23, doi. 10.7748/nop.2016.e833

By:

Mages, Linda

Publication type:

Article

Journal scan.

Published in:: 2015
Publication type:: Abstract

Supporting people with Parkinson’s in later life.

Published in:

2014

By:

Hayes, Nicky;
Surendranath, Suma

Publication type:

Journal Article

Journal scan.

Published in:: Nursing Older People, 2013, v. 25, n. 1, p. 11, doi. 10.7748/nop2013.05.25.4.11.s17
Publication type:: Article

Surgery complications linked to Parkinson's disease.

Published in:

Nursing Older People, 2011, v. 23, n. 1, p. 11, doi. 10.7748/nop.23.1.11.s17

By:

Sander, Ruth

Publication type:

Article

Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.

Published in:

BioMed Research International, 2021, p. 1, doi. 10.1155/2021/4490081

By:

Lin, Dongtao;
Zeng, Yudan;
Tang, Deyu;
Cai, Yongming

Publication type:

Article

Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.

Published in:

BioMed Research International, 2021, p. 1, doi. 10.1155/2021/1752570

By:

Liu, Yan-yun;
Yu, Li-hua;
Zhang, Juan;
Xie, Dao-jun;
Zhang, Xin-xiang;
Yu, Jia-ming

Publication type:

Article

Successful treatment for various arrhythmias in an older patient treated with pilsicainide for paroxysmal supraventricular tachycardia.

Published in:

Geriatrics & Gerontology International, 2018, v. 18, n. 10, p. 1520, doi. 10.1111/ggi.13520

By:

Etoh, Ryo;
Ishimatsu, Takashi;
Kawano, Hiroaki;
Tomichi, Yoichi;
Arakawa, Shuji;
Doi, Yoshiyuki;
Fukae, Satoki;
Maemura, Koji

Publication type:

Article

Possible serotonin syndrome with carbidopa-levodopa and linezolid.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2016, v. 41, n. 1, p. 101, doi. 10.1111/jcpt.12352

By:

Pettit, N. N.;
Alonso, V.;
Wojcik, E.;
Anyanwu, E. C.;
Ebara, L.;
Benoit, J.‐L.

Publication type:

Article

Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson's disease.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 5, p. 571, doi. 10.1111/j.1365-2710.2012.01336.x

By:

Hattori, N.;
Hasegawa, K.;
Sakamoto, T.

Publication type:

Article

Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 5, p. 578, doi. 10.1111/j.1365-2710.2012.01349.x

By:

Cutler, D. L.;
Tendolkar, A.;
Grachev, I. D.

Publication type:

Article

Distinguishing objective from subjective assessments of the severity of medication-related safety events among people with Parkinson's disease: a qualitative study.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 4, p. 436, doi. 10.1111/j.1365-2710.2011.01316.x

By:

Buetow, S.;
Henshaw, J.;
Cha, R.;
O'Sullivan, D.

Publication type:

Article

Parkinsonism and Parkinson's disease associated with long-term administration of sertraline.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2001, v. 26, n. 2, p. 111, doi. 10.1046/j.1365-2710.2001.00307.x

By:

Latorre, M.A. Pina;
Modrego, P.J.;
Rodilla, F.;
Catalan, C.;
Calvo, M.

Publication type:

Article

Circadian rhythms and influencing factors of xerostomia among Parkinson's disease patients.

Published in:

Oral Diseases, 2019, v. 25, n. 1, p. 282, doi. 10.1111/odi.12942

By:

Barbe, Anna Greta;
Ludwar, Lena;
Scharfenberg, Isabel;
Hellmich, Martin;
Dano, Richard;
Barbe, Michael Thomas;
Noack, Michael Johannes

Publication type:

Article

Rotigotine transdermal patch in combination therapy for Parkinson’s disease – observations in routine clinical practice.

Published in:

Current Medical Research & Opinion, 2011, v. 27, n. 10, p. 1899, doi. 10.1185/03007995.2011.611630

By:

Andres Ceballos-Baumann;
Hermann-Josef Häck

Publication type:

Article

Levodopa-related wearing-off in Parkinson's disease: identification and management.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 4, p. 841, doi. 10.1185/03007990902779319

By:

Rajesh Pahwa;
Kelly E. Lyons

Publication type:

Article

Naturalistic evaluation of entacapone in patients with signs and symptoms of L-dopa wearing-off .

Published in:

2008

By:

M. Jog;
M. Panisset;
O. Suchowersky;
B. Réhel;
R. Schecter;
Jog, M;
Panisset, M;
Suchowersky, O;
Réhel, B;
Schecter, R

Publication type:

journal article

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease.

Published in:

Drugs, 2002, v. 62, n. 5, p. 775, doi. 10.2165/00003495-200262050-00005

By:

Korczyn, A.D.;
Nussbaum, M.

Publication type:

Article

Zonisamide in Parkinson's Disease: An Evidence-Based Review of its Impact on Clinical Outcomes.

Published in:

Clinical Medicine Reviews in Therapeutics, 2012, v. 4, p. 89, doi. 10.4137/CMRT.S3429

By:

Skodda, Sabine

Publication type:

Article

Pimavanserin in psychiatry- novel facts vs fiction.

Published in:

Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 2021, v. 34, n. 4, p. 396, doi. 10.14744/DAJPNS.2021.00164

By:

Shoib, Sheikh;
Baiou, Alaa;
Javad, Sana;
Cevallos-Robalino, Doménica Nathaly;
Saeed, Fahimeh

Publication type:

Article